Federal (United States) · Session law
Title III
15 sections
15 sections
- Pub. L. 116-260, div. BB, tit. III, subtit. A, sec. 301EXTENSION FOR COMMUNITY HEALTH CENTERS, THE NATIONAL HEALTH SERVICE CORPS, AND TEACHING HEALTH CENTERS THAT OPERATE GME PROGRAMS.Enacted
- Pub. L. 116-260, div. BB, tit. III, subtit. A, sec. 302DIABETES PROGRAMS.Enacted
- Pub. L. 116-260, div. BB, tit. III, subtit. B, sec. 311IMPROVING AWARENESS OF DISEASE PREVENTION.Enacted
- Pub. L. 116-260, div. BB, tit. III, subtit. B, sec. 312GUIDE ON EVIDENCE-BASED STRATEGIES FOR PUBLIC HEALTH DEPARTMENT OBESITY PREVENTION PRO- GRAMS.Enacted
- Pub. L. 116-260, div. BB, tit. III, subtit. B, sec. 313EXPANDING CAPACITY FOR HEALTH OUTCOMES.Enacted
- Pub. L. 116-260, div. BB, tit. III, subtit. B, sec. 314PUBLIC HEALTH DATA SYSTEM MODERNIZATION.Enacted
- Pub. L. 116-260, div. BB, tit. III, subtit. B, sec. 315NATIVE AMERICAN SUICIDE PREVENTION.Enacted
- Pub. L. 116-260, div. BB, tit. III, subtit. B, sec. 316REAUTHORIZATION OF THE YOUNG WOMEN’S BREAST HEALTH EDUCATION AND AWARENESS REQUIRES LEARNING YOUNG ACT OF 2009.Enacted
- Pub. L. 116-260, div. BB, tit. III, subtit. B, sec. 317REAUTHORIZATION OF SCHOOL-BASED HEALTH CENTERS.Enacted
- Pub. L. 116-260, div. BB, tit. III, subtit. C, sec. 321RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER EXTENSION.Enacted
- Pub. L. 116-260, div. BB, tit. III, subtit. C, sec. 322CONDITIONS OF USE FOR BIOSIMILAR BIOLOGICAL PRODUCTS.Enacted
- Pub. L. 116-260, div. BB, tit. III, subtit. C, sec. 323ORPHAN DRUG CLARIFICATION.Enacted
- Pub. L. 116-260, div. BB, tit. III, subtit. C, sec. 324MODERNIZING THE LABELING OF CERTAIN GENERIC DRUGS.Enacted
- Pub. L. 116-260, div. BB, tit. III, subtit. C, sec. 325BIOLOGICAL PRODUCT PATENT TRANSPARENCY.Enacted
- Pub. L. 116-260, div. BB, tit. III, subtit. D, sec. 331TECHNICAL CORRECTIONS.Enacted